It seems that IGFBP7 could be considered as a plasma biomarker of chronic, ongoing myocardium damage, especially in patients with IHD, when ischemic cardiomyocytes are replaced by fibrous tissue. This evidence concerns the gene IGFBP7 and myocardial ischemia.